Bioengineering in the oral cavity: our experience
L Catalfamo,1 E Belli,2 C Nava,1 E Mici,1 A Calvo,1 B D'Alessandro,1 FS De Ponte1 1Unit of Maxillofacial Surgery, University of Messina, Azienda Ospedaliera Universitaria, Policlinico G Martino, Messina, Italy; 2Unit of Maxillofacial Surgery, University Rome Sapienza, Azienda Ospedaliera San...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/25166486d3ef4f5d826ec66ac6cd26bd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:25166486d3ef4f5d826ec66ac6cd26bd |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:25166486d3ef4f5d826ec66ac6cd26bd2021-12-02T07:22:51ZBioengineering in the oral cavity: our experience1176-91141178-2013https://doaj.org/article/25166486d3ef4f5d826ec66ac6cd26bd2013-10-01T00:00:00Zhttp://www.dovepress.com/bioengineering-in-the-oral-cavity-our-experience-a14632https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013L Catalfamo,1 E Belli,2 C Nava,1 E Mici,1 A Calvo,1 B D'Alessandro,1 FS De Ponte1 1Unit of Maxillofacial Surgery, University of Messina, Azienda Ospedaliera Universitaria, Policlinico G Martino, Messina, Italy; 2Unit of Maxillofacial Surgery, University Rome Sapienza, Azienda Ospedaliera Sant Andrea, Rome, Italy Background: To date, there are no studies reported in the literature on the possible use of bovine collagen, oxidized regenerated cellulose, or synthetic hyaluronic acid medications in the oral cavity. The aim of this paper is to report the use of bovine collagen, oxidized regenerated cellulose, and synthetic hyaluronic acid medications to improve wound healing in the oral cavity by stimulating granulomatous tissue. Methods: From 2007 to 2011, 80 patients (median age 67 years) suffering from oral mucosal lesions participated in this double-blind study. The patients were divided into two groups, each consisting of 40 patients. One group received conventional medications, while the other group of patients were treated with the advanced medications. Results: Advanced medications allowed re-epithelialization of the wound margin in 2–20 days, whereas patients receiving conventional medication showed a median healing duration of 45 days. Conclusion: The results of this study demonstrate that treating oral mucosal wounds with advanced medication has an advantage with regard to wound healing time, allowing patients to have a rapid, functional, and esthetic recovery. Keywords: bioengineering, oral cavity, mucosal recoveryCatalfamo LBelli ENava CMici ECalvo AD'Alessandro BDe Ponte FSDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2013, Iss Issue 1, Pp 3883-3886 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine (General) R5-920 |
spellingShingle |
Medicine (General) R5-920 Catalfamo L Belli E Nava C Mici E Calvo A D'Alessandro B De Ponte FS Bioengineering in the oral cavity: our experience |
description |
L Catalfamo,1 E Belli,2 C Nava,1 E Mici,1 A Calvo,1 B D'Alessandro,1 FS De Ponte1 1Unit of Maxillofacial Surgery, University of Messina, Azienda Ospedaliera Universitaria, Policlinico G Martino, Messina, Italy; 2Unit of Maxillofacial Surgery, University Rome Sapienza, Azienda Ospedaliera Sant Andrea, Rome, Italy Background: To date, there are no studies reported in the literature on the possible use of bovine collagen, oxidized regenerated cellulose, or synthetic hyaluronic acid medications in the oral cavity. The aim of this paper is to report the use of bovine collagen, oxidized regenerated cellulose, and synthetic hyaluronic acid medications to improve wound healing in the oral cavity by stimulating granulomatous tissue. Methods: From 2007 to 2011, 80 patients (median age 67 years) suffering from oral mucosal lesions participated in this double-blind study. The patients were divided into two groups, each consisting of 40 patients. One group received conventional medications, while the other group of patients were treated with the advanced medications. Results: Advanced medications allowed re-epithelialization of the wound margin in 2–20 days, whereas patients receiving conventional medication showed a median healing duration of 45 days. Conclusion: The results of this study demonstrate that treating oral mucosal wounds with advanced medication has an advantage with regard to wound healing time, allowing patients to have a rapid, functional, and esthetic recovery. Keywords: bioengineering, oral cavity, mucosal recovery |
format |
article |
author |
Catalfamo L Belli E Nava C Mici E Calvo A D'Alessandro B De Ponte FS |
author_facet |
Catalfamo L Belli E Nava C Mici E Calvo A D'Alessandro B De Ponte FS |
author_sort |
Catalfamo L |
title |
Bioengineering in the oral cavity: our experience |
title_short |
Bioengineering in the oral cavity: our experience |
title_full |
Bioengineering in the oral cavity: our experience |
title_fullStr |
Bioengineering in the oral cavity: our experience |
title_full_unstemmed |
Bioengineering in the oral cavity: our experience |
title_sort |
bioengineering in the oral cavity: our experience |
publisher |
Dove Medical Press |
publishDate |
2013 |
url |
https://doaj.org/article/25166486d3ef4f5d826ec66ac6cd26bd |
work_keys_str_mv |
AT catalfamol bioengineeringintheoralcavityourexperience AT bellie bioengineeringintheoralcavityourexperience AT navac bioengineeringintheoralcavityourexperience AT micie bioengineeringintheoralcavityourexperience AT calvoa bioengineeringintheoralcavityourexperience AT damp39alessandrob bioengineeringintheoralcavityourexperience AT depontefs bioengineeringintheoralcavityourexperience |
_version_ |
1718399446126952448 |